The Presbyterian Health Foundation and the Oklahoma Center for Therapeutic Sciences 2022 pilot award
Published: Wednesday, June 29, 2022
The Presbyterian Health Foundation (PHF) and the Oklahoma Center for Therapeutic Sciences (CTS) are soliciting proposals for Investigator Seed Grant Awards in drug and probe discovery. The current RFA is focused on funding pilot projects that utilize the Drug and Target Discovery (DTD) High Throughput Screening (HTS) Facility and the Laboratory of Molecular Structure and Function (MSF). DTD can perform screens of its 7 chemical libraries (~100,000 compounds) using cell-based high-content imaging, as well as fluorescence, fluorescence polarization, TR-FRET, absorbance, and luminescence of cell-based assays or assays using purified components. DTD has cell culture facilities and a full suite of detection, robotic, and imaging equipment designed to facilitate work in microwell plates (96-or 384-well formats). The Facility will assist investigators in the design and development of screen assays that can use all currently available assay readouts and formats. Funding for pilot projects that utilize MSF will be focused on the use of its structure-guided software tools.
Documents for the pilot award announcement and a brochure describing the capabilities of CTS are attached.
If you have any questions, please contact Matthew Hart, Ph.D. at Matthew-J-Hart@ouhsc.edu